Login
Get Started

Understanding GLP-1 Medications

What are GLP-1 medications and how were they developed?

GLP (glucagon-like peptide ) medications are a class of prescription drugs that mimic a naturally occurring hormone in your body. GLP is produced in your intestines in response to eating and plays a crucial role in regulating appetite, blood sugar, and metabolism.


These medications were originally developed to treat type 2 diabetes. Researchers noticed that patients taking GLP medications for diabetes were experiencing significant weight loss as a side effect. This led to extensive research and clinical trials specifically for weight management, resulting in FDA approval for obesity treatment.


The development of GLP medications represents one of the most significant advances in obesity medicine in decades. They address the biological and hormonal factors that make weight loss and maintenance so challenging, offering a medical solution that works with your body’s natural systems.

Androgenetic alopecia (pattern baldness) is caused by genetic sensitivity to DHT (dihydrotestosterone), a hormone created when the enzyme alpha reductase converts testosterone to DHT. In genetically susceptible individuals, DHT binds to receptors in hair follicles, causing follicular miniaturization where follicles progressively shrink, produce thinner and shorter hairs, have shorter growth cycles, and eventually become dormant.

In men, this typically presents as receding hairline starting at temples, thinning at the crown, and progressive loss following predictable patterns (Norwood scale). In women, it presents as diffuse thinning across the top of the scalp, widening part line, generally preserved hairline, and less complete baldness than men (Ludwig scale).

The process is gradual over years or decades, influenced by genetics (from both parents, not just maternal grandfather), hormones (DHT sensitivity), age (typically starts but can begin earlier), and other factors like stress, nutrition, medications, and underlying health conditions. Understanding the cause is crucial because it explains why effective treatments must address DHT and follicular stimulation.

Androgenetic alopecia (pattern baldness) is caused by genetic sensitivity to DHT (dihydrotestosterone), a hormone created when the enzyme alpha reductase converts testosterone to DHT. In genetically susceptible individuals, DHT binds to receptors in hair follicles, causing follicular miniaturization where follicles progressively shrink, produce thinner and shorter hairs, have shorter growth cycles, and eventually become dormant.

In men, this typically presents as receding hairline starting at temples, thinning at the crown, and progressive loss following predictable patterns (Norwood scale). In women, it presents as diffuse thinning across the top of the scalp, widening part line, generally preserved hairline, and less complete baldness than men (Ludwig scale).

The process is gradual over years or decades, influenced by genetics (from both parents, not just maternal grandfather), hormones (DHT sensitivity), age (typically starts but can begin earlier), and other factors like stress, nutrition, medications, and underlying health conditions. Understanding the cause is crucial because it explains why effective treatments must address DHT and follicular stimulation.

Androgenetic alopecia (pattern baldness) is caused by genetic sensitivity to DHT (dihydrotestosterone), a hormone created when the enzyme alpha reductase converts testosterone to DHT. In genetically susceptible individuals, DHT binds to receptors in hair follicles, causing follicular miniaturization where follicles progressively shrink, produce thinner and shorter hairs, have shorter growth cycles, and eventually become dormant.

In men, this typically presents as receding hairline starting at temples, thinning at the crown, and progressive loss following predictable patterns (Norwood scale). In women, it presents as diffuse thinning across the top of the scalp, widening part line, generally preserved hairline, and less complete baldness than men (Ludwig scale).

The process is gradual over years or decades, influenced by genetics (from both parents, not just maternal grandfather), hormones (DHT sensitivity), age (typically starts but can begin earlier), and other factors like stress, nutrition, medications, and underlying health conditions. Understanding the cause is crucial because it explains why effective treatments must address DHT and follicular stimulation.

Androgenetic alopecia (pattern baldness) is caused by genetic sensitivity to DHT (dihydrotestosterone), a hormone created when the enzyme alpha reductase converts testosterone to DHT. In genetically susceptible individuals, DHT binds to receptors in hair follicles, causing follicular miniaturization where follicles progressively shrink, produce thinner and shorter hairs, have shorter growth cycles, and eventually become dormant.

In men, this typically presents as receding hairline starting at temples, thinning at the crown, and progressive loss following predictable patterns (Norwood scale). In women, it presents as diffuse thinning across the top of the scalp, widening part line, generally preserved hairline, and less complete baldness than men (Ludwig scale).

The process is gradual over years or decades, influenced by genetics (from both parents, not just maternal grandfather), hormones (DHT sensitivity), age (typically starts but can begin earlier), and other factors like stress, nutrition, medications, and underlying health conditions. Understanding the cause is crucial because it explains why effective treatments must address DHT and follicular stimulation.

Androgenetic alopecia (pattern baldness) is caused by genetic sensitivity to DHT (dihydrotestosterone), a hormone created when the enzyme alpha reductase converts testosterone to DHT. In genetically susceptible individuals, DHT binds to receptors in hair follicles, causing follicular miniaturization where follicles progressively shrink, produce thinner and shorter hairs, have shorter growth cycles, and eventually become dormant.

In men, this typically presents as receding hairline starting at temples, thinning at the crown, and progressive loss following predictable patterns (Norwood scale). In women, it presents as diffuse thinning across the top of the scalp, widening part line, generally preserved hairline, and less complete baldness than men (Ludwig scale).

The process is gradual over years or decades, influenced by genetics (from both parents, not just maternal grandfather), hormones (DHT sensitivity), age (typically starts but can begin earlier), and other factors like stress, nutrition, medications, and underlying health conditions. Understanding the cause is crucial because it explains why effective treatments must address DHT and follicular stimulation.

Effectiveness and
Results

How much weight can I realistically expect to lose?

Sermorelin is a bioidentical synthetic peptide that consists of the first 29 amino acids of growth hormone releasing hormone (GHRH). Your pituitary gland naturally produces GHRH to signal the release of growth hormone. As we age, both GHRH and growth hormone levels decline, contributing to many signs of aging. Sermorelin mimics natural GHRH, restoring the signal that tells your pituitary to produce growth hormone in a natural, pulsatile pattern similar to what occurred when you were younger.

Safety and Side Effects

What are the most common side effects?

Sermorelin is a bioidentical synthetic peptide that consists of the first 29 amino acids of growth hormone releasing hormone (GHRH). Your pituitary gland naturally produces GHRH to signal the release of growth hormone. As we age, both GHRH and growth hormone levels decline, contributing to many signs of aging. Sermorelin mimics natural GHRH, restoring the signal that tells your pituitary to produce growth hormone in a natural, pulsatile pattern similar to what occurred when you were younger.

Treatment Logistics

What does treatment cost and is it covered by insurance?

Sermorelin is a bioidentical synthetic peptide that consists of the first 29 amino acids of growth hormone releasing hormone (GHRH). Your pituitary gland naturally produces GHRH to signal the release of growth hormone. As we age, both GHRH and growth hormone levels decline, contributing to many signs of aging. Sermorelin mimics natural GHRH, restoring the signal that tells your pituitary to produce growth hormone in a natural, pulsatile pattern similar to what occurred when you were younger.

Sermorelin is a bioidentical synthetic peptide that consists of the first 29 amino acids of growth hormone releasing hormone (GHRH). Your pituitary gland naturally produces GHRH to signal the release of growth hormone. As we age, both GHRH and growth hormone levels decline, contributing to many signs of aging. Sermorelin mimics natural GHRH, restoring the signal that tells your pituitary to produce growth hormone in a natural, pulsatile pattern similar to what occurred when you were younger.

Sermorelin is a bioidentical synthetic peptide that consists of the first 29 amino acids of growth hormone releasing hormone (GHRH). Your pituitary gland naturally produces GHRH to signal the release of growth hormone. As we age, both GHRH and growth hormone levels decline, contributing to many signs of aging. Sermorelin mimics natural GHRH, restoring the signal that tells your pituitary to produce growth hormone in a natural, pulsatile pattern similar to what occurred when you were younger.

Sermorelin is a bioidentical synthetic peptide that consists of the first 29 amino acids of growth hormone releasing hormone (GHRH). Your pituitary gland naturally produces GHRH to signal the release of growth hormone. As we age, both GHRH and growth hormone levels decline, contributing to many signs of aging. Sermorelin mimics natural GHRH, restoring the signal that tells your pituitary to produce growth hormone in a natural, pulsatile pattern similar to what occurred when you were younger.

Sermorelin is a bioidentical synthetic peptide that consists of the first 29 amino acids of growth hormone releasing hormone (GHRH). Your pituitary gland naturally produces GHRH to signal the release of growth hormone. As we age, both GHRH and growth hormone levels decline, contributing to many signs of aging. Sermorelin mimics natural GHRH, restoring the signal that tells your pituitary to produce growth hormone in a natural, pulsatile pattern similar to what occurred when you were younger.

For questions not covered here, please contact your Connect Med provider. We’re here to support your hair restoration journey every step of the way.

Long-term Success

How do I maintain my weight loss long-term?

Sermorelin is a bioidentical synthetic peptide that consists of the first 29 amino acids of growth hormone releasing hormone (GHRH). Your pituitary gland naturally produces GHRH to signal the release of growth hormone. As we age, both GHRH and growth hormone levels decline, contributing to many signs of aging. Sermorelin mimics natural GHRH, restoring the signal that tells your pituitary to produce growth hormone in a natural, pulsatile pattern similar to what occurred when you were younger.

Sermorelin is a bioidentical synthetic peptide that consists of the first 29 amino acids of growth hormone releasing hormone (GHRH). Your pituitary gland naturally produces GHRH to signal the release of growth hormone. As we age, both GHRH and growth hormone levels decline, contributing to many signs of aging. Sermorelin mimics natural GHRH, restoring the signal that tells your pituitary to produce growth hormone in a natural, pulsatile pattern similar to what occurred when you were younger.

Sermorelin is a bioidentical synthetic peptide that consists of the first 29 amino acids of growth hormone releasing hormone (GHRH). Your pituitary gland naturally produces GHRH to signal the release of growth hormone. As we age, both GHRH and growth hormone levels decline, contributing to many signs of aging. Sermorelin mimics natural GHRH, restoring the signal that tells your pituitary to produce growth hormone in a natural, pulsatile pattern similar to what occurred when you were younger.

Sermorelin is a bioidentical synthetic peptide that consists of the first 29 amino acids of growth hormone releasing hormone (GHRH). Your pituitary gland naturally produces GHRH to signal the release of growth hormone. As we age, both GHRH and growth hormone levels decline, contributing to many signs of aging. Sermorelin mimics natural GHRH, restoring the signal that tells your pituitary to produce growth hormone in a natural, pulsatile pattern similar to what occurred when you were younger.

Sermorelin is a bioidentical synthetic peptide that consists of the first 29 amino acids of growth hormone releasing hormone (GHRH). Your pituitary gland naturally produces GHRH to signal the release of growth hormone. As we age, both GHRH and growth hormone levels decline, contributing to many signs of aging. Sermorelin mimics natural GHRH, restoring the signal that tells your pituitary to produce growth hormone in a natural, pulsatile pattern similar to what occurred when you were younger.

For questions not covered here, please contact your Connect Med provider. We’re here to support your hair restoration journey every step of the way.